Although the TGA oversees access, most medicinal cannabis products are deemed unapproved medicines.
Unapproved medicines have not been evaluated by the TGA for safety, quality, or effectiveness.
Nonetheless, when clinically suitable, there are pathways available for registered healthcare professionals to obtain medicinal cannabis products for their patients.